Evidence map›Paper›PMID 11904424›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Integrins regulate the apoptotic response to DNA damage through modulation of p53.

Jean McArthur Lewis, Tony Nguyen Truong, Martin Alexander Schwartz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 98 citations in OpenAlex.

  1. Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Integrins in the Spotlight of Cancer.International journal of molecular sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jean McArthur LewisDepartment of Vascular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, CVN228/VB4, La Jolla, CA 92037, USA.
Tony Nguyen Truong
Martin Alexander Schwartz
Scripps Research Institute · USHarvard University · US

Funding

REGULATION OF SECOND MESSENGERS BY BETA3 INTEGRINS IN THE VASCULAR SYSTEMP01HL048728 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI GINSBERG, MARK HOWARD · 1992 to 2003
$7.4M
C ABL TYROSINE KINASE IN INTEGRIN DEPENDENT SIGNALINGR29CA074230 · NCI · SCRIPPS RESEARCH INSTITUTE · PI LEWIS, JEAN M · 1998 to 2001
$248k
NCI NIH HHS R29 CA74230NHLBI NIH HHS P01 HL48728
6 · The paper itself

Abstract

p53 mediates apoptosis of cells after DNA damage including tumor cells after radiation or chemotherapy. Survival of isolated cancer cells after therapy leads to recurrence of therapy-resistant tumors. We now show that for some melanoma, sarcoma, or fibroblastic cell types that survive without integrin-mediated adhesion, apoptosis in response to DNA damage requires cell adhesion. This effect correlates with rapid changes in levels of p14/p19 Arf and its downstream component, p53. Killing of nonadherent cells is increased by treatment with antiintegrin antibodies or by increasing levels of p53 or Arf. Consistent with low p53 levels, suspended cells show chromosomal instability after irradiation. Thus, loss of normal adhesion in susceptible tumor cells during genotoxic stress may play a role in therapy resistance and promote survival of cells with aberrant DNA.

Indexed as

ApoptosisDNA DamageNuclear ProteinsAnimalsAntibodiesCaspase 3CaspasesCell AdhesionCell SurvivalChromosome AberrationsCyclin-Dependent Kinase Inhibitor p16FibroblastsHumansIntegrinsMelanomaMiceAntibodiesCASP3 protein, humanCasp3 protein, mouseCaspase 3CaspasesCdkn2a protein, mouseCyclin-Dependent Kinase Inhibitor p16IntegrinsMDM2 protein, humanMdm2 protein, mouseNuclear ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p14ARFTumor Suppressor Protein p53

Identifiers

PMID11904424
PMCPMC122574
OpenAlexW2081800928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.